STOCK TITAN
  1. Home
  2. Financials
  3. CNBX
  4. EPS (Diluted)

CNBX Pharmaceutical (CNBX) EPS by Year

CNBX OTC

CNBX Pharmaceutical Inc earned $0.00 per diluted share in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters CNBX Pharmaceutical Inc has filed alongside them.

FY2025 annual
EPS (Diluted) $0.00
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNBX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)$0.00-$0.02-$0.42n/m-$3.59-$0.02-$0.10-600.0%$0.02-$0.03n/m-$0.02n/m$0.00n/m-$0.01n/m-$0.01-$0.04$0.00n/m-$0.16

CNBX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)$0.00$0.00$0.00N/A$0.00$0.00$0.00n/m$0.00$0.00-$0.01-$0.01N/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More CNBX Pharmaceutical Inc financials

Frequently Asked Questions

CNBX Pharmaceutical Inc earned $0.00 per diluted share in fiscal year 2025.

Across the 15 fiscal years this page covers, CNBX Pharmaceutical Inc (CNBX) diluted earnings per share went from -$0.16 in fiscal year 2011 to $0.00 in fiscal year 2025.

CNBX Pharmaceutical Inc (CNBX) reported $0.00 in diluted earnings per share in Q3 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CNBX Pharmaceutical Inc (CNBX) reported on that line in every period on record.